Evidence map›Paper›PMID 25878079›Full record

ArticleBritish journal of sports medicine2015

Antidoping programme and biological monitoring before and during the 2014 FIFA World Cup Brazil.

Norbert Baume, Nicolas Jan, Caroline Emery, Béatrice Mandanis, Carine Schweizer, Sylvain Giraud, Nicolas Leuenberger, François Marclay, Raul Nicoli, Laurent Perrenoud and 3 more

Abstract read
In one paragraph

Article in British journal of sports medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Norbert BaumeSwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
Nicolas JanSwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
Caroline EmerySwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
Béatrice MandanisSwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
Carine SchweizerSwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
Sylvain GiraudSwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
Nicolas LeuenbergerSwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
François MarclaySwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
Raul NicoliSwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
Laurent PerrenoudSwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
Neil RobinsonSwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.
Jiri DvorakFIFA, Zürich, Switzerland FIFA Medical Assessment and Research Centre (F-MARC) and Schulthess Clinic, Zürich, Switzerland.
Martial SaugySwiss Laboratory for Doping Analyses, University Center of Legal Medicine, Geneva & Lausanne, Epalinges, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe FIFA has implemented an important antidoping programme for the 2014 FIFA World Cup.

aimTo perform the analyses before and during the World Cup with biological monitoring of blood and urine samples.

methodsAll qualified players from the 32 teams participating in the World Cup were tested out-of-competition. During the World Cup, 2-8 players per match were tested. Over 1000 samples were collected in total and analysed in the WADA accredited Laboratory of Lausanne.

resultsThe quality of the analyses was at the required level as described in the WADA technical documents. The urinary steroid profiles of the players were stable and consistent with previously published papers on football players. During the competition, amphetamine was detected in a sample collected on a player who had a therapeutic use exemption for attention deficit hyperactivity disorder. The blood passport data showed no significant difference in haemoglobin values between out-of-competition and postmatch samples.

conclusionsLogistical issues linked to biological samples collection, and the overseas shipment during the World Cup did not impair the quality of the analyses, especially when used as the biological passport of football players.

Indexed as

AmphetamineAndrostenedioneBlood Chemical AnalysisBrazilClenbuterolDoping in SportsGlucocorticoidsHumansSoccerSpecimen HandlingSteroidsSubstance Abuse DetectionTramadolUrinalysisAmphetamineAndrostenedioneClenbuterolformestaneGlucocorticoidsSteroidsTramadolFootball

Identifiers

PMID25878079
PMCPMC4413745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.